Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Gross Margin (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Gross Margin came in at 51.98% for Q2 2026, up 1.64 percentage points from 50.34% a year earlier and up 2.46 percentage points from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Gross Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Teva Pharmaceutical Industries reported Gross Margin of 52.47%, up 2.87 percentage points year-over-year; for FY2025, it was 51.79%, up 3.05 percentage points from FY2024.

  • Gross Margin has increased in each of the last three years, with a five-year change of +5.41 percentage points (FY2020 to FY2025).
  • Going back by year, Gross Margin was 48.74% in FY2024 (+0.50 pp), 48.25% in FY2023 (+1.53 pp), 46.72% in FY2022 (-1.11 pp) and 47.83% in FY2021 (+1.45 pp).
  • The five-year range for quarterly Gross Margin is 43.21% (Q1 2023) to 56.38% (Q4 2025).
  • Year-over-year, Gross Margin has increased for six consecutive quarters, with an average year-over-year change of +1.51 percentage points over the last eight quarters.
  • The fastest year-over-year change in Gross Margin over five years came in Q4 2023 (a gain of 8.61 percentage points), and the weakest in Q4 2022 (a drop of 4.43 percentage points).
  • Business Quant data shows TEVA's Gross Margin at 49.52% (Q1 2026), 56.38% (Q4 2025) and 51.43% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 51.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.98%
Mar 31, 2026 49.52%
Dec 31, 2025 56.38%
Sep 30, 2025 51.43%
Jun 30, 2025 50.34%
Mar 31, 2025 48.24%
Dec 31, 2024 50.15%
Sep 30, 2024 49.58%
Jun 30, 2024 48.61%
Mar 31, 2024 46.37%
Dec 31, 2023 54.18%
Sep 30, 2023 48.08%
Jun 30, 2023 46.31%
Mar 31, 2023 43.21%
Dec 31, 2022 45.57%
Sep 30, 2022 46.43%
Jun 30, 2022 47.39%
Mar 31, 2022 47.53%
Dec 31, 2021 50.00%
Sep 30, 2021 46.15%
API Access

Teva Pharmaceutical Industries Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=TEVA&period=max&api_key=YOUR_API_KEY